Aptamers Market by Type (Nucleic Acid and Peptide Aptamers), Application (Diagnostics, Therapeutics Development), Technology (Selex, X-aptamer and MARAS technique), End Users (Biotechnology and Pharmaceutical Companies)- Forecast 2027

ID: VPR/HC/1059 Publishing Year: January 2022 Pages: 62 Format:   


Aptamers Market Overview:

The Aptamers Market is projected to grow from USD 220 Billion in 2020 to reach USD 684 Billion by 2027; it is expected to grow at a CAGR of 17.59% from 2020 to 2027.

The expansion of the Aptamers Market has been fueled by a growing focus on research and development efforts in the biotechnology and pharmaceutical sectors to launch novel medicinal products.

Aptamers are single-stranded DNA and RNA molecules that can bind to a specific target with high specificity. Aptamers come in a range of forms thanks to their proclivity for forming helices and single-stranded loops. These can be made fast and used to inhibit and characterise proteins, and they can also be designed to have improved specificity and affinity. These flexible compounds bind to a variety of targets, including proteins, peptides, small molecules, toxins, carbohydrates, and even live cells. Aptamers are usually produced through a selection process from a vast pool of random sequences, and they can be used in both therapeutic and scientific settings.

The low cost and great efficiency of Aptamersin binding to large molecules as compared to antibodies, as well as an increased focus on improving the technology, are driving the market value of Aptamers. The market for Aptamershas grown due to increased research and development capabilities in the biotechnology and pharmaceutical industries. The increased use of Aptamersfor drug discovery and illness treatment, as well as expanded recombinant product production, has created attractive Aptamers Market Growth Potential. Growing FDA approvals have also aided market growth and accelerated the rate of market expansion.

Key Players:

Some of the Key Players in the Global Aptamers Market are Aptamer Sciences, Inc., Aptagen, LLC, Base Pair Biotechnologies, Inc., Ophthotech Corporation, Am Biotechnologies, LLC, Aptamer Solutions Ltd., Aptus Biotech S.L., Neoventures Biotechnology Inc., Somalogic, Inc., Trilink Biotechnologies, Inc., Vivonics, Inc., NoxxonPharma, and others.

Market Growth:

Furthermore, the rising prevalence of life-threatening diseases such as cancer has prompted numerous companies to develop novel aptamer-based detection techniques. Aptamer Sciences, Inc. revealed a multiprotein biomarker assay for lung cancer detection utilising this technique in March 2017. This kit is meant to discover a relevant biomarker for early detection and diagnosis of non-small cell lung cancer. Such new product launches are projected to accelerate the acceptability of these medicines, resulting in significant market growth. Furthermore, an increasing number of small-scale startups, government organisations, goods under clinical evaluation, and academic research laboratories investigating the potential of aptamers are expected to promote future market growth.

Market Segmentation:

The Global Aptamers Market is Segmentedby type, application, technology, and end user in this report. DNA-based, RNA-based, and XNA-based aptamers are among the global market product segments covered in the report. The Global Market for DNA-based aptamers is predicted to account for the highest proportion in 2015. General diagnostics, medicines development, R&D, and other applications are among the applications covered in this research. Diagnostics is predicted to account for the greatest part of the global market in 2015.

The market is divided into two categories based on technology: SELEX and other technologies. The SELEX segment is predicted to have the greatest share of the global market in 2015. Academic and government research institutes, biotechnology and pharmaceutical firms, contract research organisations (CROs), and other end users are the segments of the global market report. The academia and government research institutes sector of the global aptamers market is estimated to account for the highest proportion of the market in 2015.

Regional Analysis:

Because of its early acceptance of sophisticated medical technologies and significant investment and financing to assist the development of aptamers, North America is expected to account for the biggest market share in the Aptamers Market. The market is also boosted by other factors such as rising demand for Aptamertherapies and an increase in the number of research institutes.

The European market is predicted to account for the second-largest proportion of the market. Factors like as rising research costs, technological advancements, declining human health, and the need for novel and effective cures all contribute to the market's growth in this region. The expanding number of small-scale start-ups, government organisations, goods under clinical investigation, and academic research laboratories investigating the potential of Aptamersare all expected to contribute to the market's future growth.

Covid-19 Impact:

COVID-19 is an unprecedented global public health crisis that has impacted practically every business, and its long-term repercussions are expected to have an influence on industry growth during the forecast period. The ongoing research involves enhancing the research framework to guarantee that underlying COVID-19 concerns and potential solutions are included. The research examines COVID-19 in light of changes in consumer behaviour and demand, purchasing patterns, supply chain re-routing, market dynamics, and government involvement. The updated study considers the impact of COVID-19 on the market and provides insights, analysis, projections, and forecasts.



Frequently Asked Questions
Aptamers Market is predicted to grow at 17.59% through forecast period of 2020-2027
By 2027, worth USD 684 Billion is estimated for the Aptamers Market.
Such new product launches are projected to accelerate the acceptability of these medicines, resulting in significant market growth.
Inc., Aptagen, LLC, Base Pair Biotechnologies, Inc., Ophthotech Corporation, Am Biotechnologies, LLC, Aptamer Solutions Ltd., Aptus Biotech S.L., Neoventures Biotechnology Inc., Somalogic, Inc., Trilink Biotechnologies, Inc., Vivonics, Inc., NoxxonPharma

Type Here for table of content.


PURCHASE OPTIONS




    ADD TO CART

CONTACT US
CALL US ON
( +91-935-919-4956 )

CONTACT EMAIL
[email protected]
PURCHASE OPTIONS




    ADD TO CART

CONTACT US
CALL US ON
( +91-935-919-4956 )

CONTACT EMAIL
[email protected]